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Histone acetyltransferases (HATs) and histone
deacetylases (HDACs) conduct many critical func-
tions through nonhistone substrates in metazoans,
butonly chromatin-associatednonhistonesubstrates
are known in Saccharomyces cerevisiae. Using yeast
proteome microarrays, we identified and validated
manynonchromatin substrates of the essential nucle-
osome acetyltransferase of H4 (NuA4) complex.
Among these, acetylation sites (Lys19 and 514) of
phosphoenolpyruvate carboxykinase (Pck1p) were
determined by tandem mass spectrometry. Acetyla-
tion at Lys514 was crucial for enzymatic activity and
the ability of yeast cells to grow on nonfermentable
carbon sources. Furthermore, Sir2p deacetylated
Pck1p both in vitro and in vivo. Loss of Pck1p activity
blocked the extension of yeast chronological life span
caused by water starvation. In human hepatocellular
carcinoma (HepG2) cells, human Pck1 acetylation
and glucose production were dependent on TIP60,
the human homolog of ESA1. Our findings demon-
strate a regulatory function for the NuA4 complex in
glucosemetabolismand life spanbyacetylatingacrit-
ical metabolic enzyme.
INTRODUCTION
Acetylation and deacetylation of histone lysine residues are
among the best characterized posttranslational modifications,and control many chromatin-related processes (Kouzarides,
2007; Millar and Grunstein, 2006). There are over 20 histone ace-
tyltransferases (HATs) and histone deacetylases (HDACs) in
S. cerevisiae (Lee and Workman, 2007; Shahbazian and Grun-
stein, 2007), among which only Esa1p, the catalytic enzyme of
NuA4, is essential for cell viability (Allard et al., 1999; Clarke
et al., 1999; Smith et al., 1998). Esa1, with Epl1p and Yng2p,
forms the ‘‘piccolo NuA4’’ core that acetylates the N-terminal
tails of histones H2A, H4, and Htz1p in vivo (Babiarz et al.,
2006; Boudreault et al., 2003; Keogh et al., 2006; Millar et al.,
2006). NuA4 is critical for regulating gene transcription, limiting
the spread of silent heterochromatin, maintaining cell cycle
progression and repairing DNA double-strand breaks. The NuA4
complex is highly conserved from yeast to humans (Auger
et al., 2008); the TIP60 complex, the human homolog of NuA4,
is important for efficient DNA damage repair and maintenance
of apoptotic competence (Ikura et al., 2000). Several recent
large-scale yeast genetic interaction screens have implied func-
tional relationships between HATs/HDACs and many extranu-
clear proteins (Lin et al., 2008; Mitchell et al., 2008). Previous
gene expression studies showed that although global downre-
gulation of acetylation profoundly affected gene expression
(Takahashi et al., 2006), dysfunction of the individual major
HATs and HDACs resulted in only minor transcriptional alter-
ations of distinct gene sets (Huisinga and Pugh, 2004; Robyr
et al., 2002; Zhang et al., 2004), suggesting that these enzymes
regulate specific extranuclear functions through mechanisms
other than transcriptional control, such as (de)acetylation of
nonhistone substrates. Most recently, several chromatin-
associated proteins were found to be acetylated in yeast,
including a cohesin subunit (Smc3p) acetylated by Eco1p
(Ben-Shahar et al., 2008; Unal et al., 2008; Zhang et al., 2008),
an RSC chromatin remodeling complex subunit (Rsc4p)Cell 136, 1073–1084, March 20, 2009 ª2009 Elsevier Inc. 1073
acetylated by Gcn5p (Choi et al., 2008; VanDemark et al., 2007),
and a subunit of NuA4 (Yng2p) acetylated by Esa1p (Lin et al.,
2008). However, nonchromatin substrates of HATs/HDACs
have not been reported in yeast despite the identification of
many such acetylation substrates in higher organisms (Yang
and Seto, 2008a, 2008b). Full understanding of the molecular
functions of these enzymes requires the identification of non-
chromatin substrates.
The enzymatic activities of HATs and HDACs are closely
related to the metabolic condition of the cells, whereas acetyla-
tion and deacetylation of metabolic enzymes also plays a pivotal
role in adaptation of the cells to changing energy status (Schwer
and Verdin, 2008). In yeast, histone acetylation and global gene
transcription is directly regulated by abundance of a key meta-
bolic intermediate, acetyl-CoA, which in turn is determined by
nucleocytoplasmic acetyl-CoA synthetase activity (Takahashi
et al., 2006). In mammals, the cytoplasmic acetyl-CoA synthe-
tase 1 (AceCS1) is deacetylated and activated by SIRT1, an
NAD+-dependent HDAC (Hallows et al., 2006). A large number
of cytoplasmic and mitochondrial metabolic enzymes were
recently reported to be subject to (de)acetylation in mammals
(Kim et al., 2006), but the responsible (de)acetylases remain
largely unknown.
The intersection of metabolism and protein (de)acetylation is
further reflected by the links between sirtuins and life span regu-
lation in yeast, worms, fruit flies, and possibly mammals (Guar-
ente and Picard, 2005; Schwer and Verdin, 2008). In yeast,
limiting the concentration of either glucose or amino acids in
the medium can lengthen both replicative life span (RLS; defined
as the number of mitotic divisions occurring in a mother cell
before senescence) and chronological life span (CLS; defined
as the period of time for a cell to survive in stationary phase) (Fab-
rizio et al., 2005; Lin et al., 2000; Powers et al., 2006). SIR2 plays
an antagonistic role in the extension of CLS under water starva-
tion (Fabrizio et al., 2005). Although the detailed mechanism is
largely unknown, the effect of SIR2 on CLS is partly mediated
by SIR2-dependent inactivation of alcohol dehydrogenase 2
(ADH2), which depletes extracellular ethanol, a proposed central
mediator of chronological longevity in yeast (Fabrizio et al.,
2005). Although ethanol was shown to be critical in this longevity
paradigm, and the requirement for deacetylase activity in block-
ing extreme life-span extension was demonstrated, no relevant
Sir2 substrate(s) were identified.
Here, we report 13 nonchromatin substrates of the NuA4
complex identified by a protein acetylationmicroarray approach.
In-depth analysis of one substrate, Pck1p, provides evidence of
a metabolic enzyme (de)acetylation state controlling the gluco-
neogenic flux in the yeast and possibly human cells. Remark-
ably, Pck1p acetylation is necessary and sufficient for extension
of yeast chronological longevity under water starvation.
RESULTS
Identification of Nonhistone NuA4 Substrates Using
Proteome Microarrays
To fully understand the molecular functions of the NuA4
complex, we sought its substrates using yeast proteome micro-
arrays (Lu et al., 2008; Zhu et al., 2001). First, we developed an1074 Cell 136, 1073–1084, March 20, 2009 ª2009 Elsevier Inc.in vitro acetylation reaction on a pilot microarray containing
histones H3, H4, and bovine serum albumin (BSA). To optimize
reaction conditions and surface chemistry (Tao et al., 2007),
we performed the assay using both the NuA4 and Spt-Ada-
Gcn5-acetyltransferase (SAGA) complexes and [14C]-acetyl-
CoA as a labeling reagent on three surfaces at various reaction
temperatures and times. NuA4 and SAGA complexes showed
preference for H4 and H3, respectively, as expected (Sterner
and Berger, 2000) on the FAST (nitrocellulose) slide (see
Figure S1 available online). No detectable signals were observed
for BSA. We then carried out acetylation reactions in duplicate
with the NuA4 complex on proteome microarrays containing
5800 yeast proteins (Zhu et al., 2001). We found that 91 proteins
were readily acetylated by NuA4 (see Figure 1A and Table S1 for
a full list of candidate substrates). Gene ontology (GO) analysis
indicated that these candidate substrates were enriched for
nucleosome assembly and histone binding activities, and
depleted for mitochondrial and membrane-associated proteins,
as expected. However, significant proportions (p < 104) of the
candidate substrates are cytoplasmic proteins such as Pck1p.
Therefore, we chose 20 candidates involved in regulatingmetab-
olism (Glk1p, Gph1p, Gsy2p, Pck1p, Sip2p, Sip5p, and Tap42p),
transcription (Nnt1p and Ume1p), cell cycle progression
(Cdc34p, Ctf4p, Rpt5p, and Skp1p), RNA processing (Brx1p
and Prp19p), and stress response (Atg3p, Atg11p, Hsp104p,
Imp20p, and Plp2p) for further validation.
We tested the ability of the NuA4 complex to acetylate these
candidate substrates using standard in vitro activity assays
(Smith et al., 1998) and confirmed 13 substrates (Atg3p,
Atg11p, Brx1p, Cdc34p, Gph1p, Hsp104p, Nnt1p, Pck1p,
Prp19p, Rpt5p, Sip2p, Sip5p, and Tap42p), as detected by
immunoprecipitation (IP) with a monoclonal anti-pan-acetyl-
lysine antibody (Li et al., 2007; Figures 1B and S2A), followed
by immunoblotting with an anti-TAG antibody. Because in vitro
enzymatic assays could suffer from promiscuity caused by non-
physiologic conditions created in the experiments, we further
validated the substrates with in vivo experiments performed in
an ESA1 Ts (esa1-531) mutant (Lin et al., 2008). We found that
all the in vitro substrates were also acetylated in the wild-type
(WT) cells; their acetylated fractions dramatically diminished in
esa1-531 at nonpermissive temperature (Figure 1C and
Figure S2B). Furthermore, the in vivo acetylation signals in the
IP assay could be efficiently competed with lysine-acetylated
BSA (Ac-K-BSA), indicating the specificity of the detected acet-
ylation signals (Figure S3). Together, these data suggested that
Gph1p, Pck1p, Sip2p, Sip5p, Tap42p, Nnt1p, Cdc34p, Rpt5p,
Brx1p, Prp19p, Atg3p, Atg11p, and Hsp104p are in vivo
substrates of Esa1p.
Pck1p Is Acetylated by NuA4 and Deacetylated
by Sir2p at K514
More than half the confirmed in vivo substrates of NuA4 are
enzymes (Atg3p, Gph1p, and Pck1p) or effectors (Atg11p,
Sip2p, Sip5p, and Tap42p) involved in signaling pathways
responsive to nutrient availability and energy status. To explore
the possible link between NuA4 acetylation and metabolism,
we focused on Pck1p for several reasons. First, it is a cytosolic
nonchromatin substrate. Second, it is a well-studied enzyme
A Figure 1. A Protein Acetylation Microarray Identifies
Yeast NuA4 Substrates
(A) Acetylation reactions on a yeast proteomemicroarray fabri-
cated on the FAST surface. A total of 91 proteins were acety-
lated by the NuA4 complex.
(B) In vitro validation of seven representative candidate
substrates. GST fusion proteins were purified from the esa1-
531 mutant grown at nonpermissive temperature and incu-
bated with/without (±) the NuA4 complex in vitro. The reaction
complex was immunoprecipitated with anti-pan-acetyl-lysine
(a-Ac-K) followed by immunoblotting with anti-glutathione-S-
transferase (a-GST).
(C) Identification of five in vivo substrates (Pck1p, Cdc34p,
Prp19p, Gph1p, and Tap42p) of the NuA4 complex. Overex-
pressed GST fusion proteins were purified from WT and
esa1-531 mutant grown at nonpermissive temperature, and
immunoprecipitated with a-Ac-K followed by immunoblotting
with a-GST.(Baly et al., 1985; Hanson andReshef, 1997). Finally, it seemed to
provide a potential insight into a poorly understood connection
between acetylation and metabolism. Moreover, the important
role of the human enzyme in diabetes (Burgess et al., 2007; Per-
mutt and Hattersley, 2000) and prolonged life span in mice over-
expressing PCK1 (Hakimi et al., 2007) made it interesting. PCK1
encodes the intricately regulated phosphoenolpyruvate carbox-
ykinase (PEPCK), catalyzing the rate-limiting step in gluconeo-
genesis by converting oxaloacetate (OAA) and ATP to phospho-
enolpyruvate (PEP), ADP, and CO2. We applied tandem mass
spectrometric (MS/MS) analysis and identified lysines 19 (K19)
and 514 (K514) as potential acetylation sites for the NuA4
complex (Figure S4). A K514 argininemutant (K514R) was gener-
ated to test association of acetylation of Pck1p with NuA4
activity. In vitro and in vivo assays showed that NuA4-dependent
acetylation of overproduced Pck1p (Figures 2A–2C) or endoge-
nously expressed (Figure 2D) was almost completely dependent
on K514, suggesting that NuA4 acetylates Pck1p at K514.
B
C
Conversely, acetylation at K19 is far less abundant
than K514 in vivo (Figure 2E), and a K19R mutation
did not affect efficient acetylation by NuA4 in vitro
(Figure 2F).
Because acetylation is reversible, we applied
a similar in vivo approach to search for Pck1p
deacetylase. A substantial increase of acetylated
Pck1p was observed in the sir2D mutant, but not
in hda1D or rpd3D mutants (Figure 3A). SIR2
encodes an NAD+-dependent HDAC involved in
chromatin silencing (Rusche et al., 2003), and the
other two encode major HDACs governing global
histone deacetylation and transcriptional control
(Vogelauer et al., 2000). Moreover, affinity-purified
Sir2p, but not Hda1p (Figure S5), effectively deace-
tylated purified Pck1p in vitro in an NAD+-depen-
dent reaction (Figure 3B). Acetylation of endoge-
nous Pck1p increased significantly in the sir2D
mutant (Figure 2D); in summary, Esa1p and Sir2p
specifically catalyze reversible (de)acetylation at K514 of Pck1
in vivo.
PCK1 mRNA and protein are highly induced during a diauxic
shift, i.e., the glycolysis to gluconeogenesis shift as glucose is
depleted (Schuller, 2003; Zaman et al., 2008). To determine
whether (de)acetylation of Pck1p controls its induction, we
compared endogenous protein levels of chromosomally tagged
Pck1p in esa1-531, sir2D, gcn5D (the catalytic subunit of the
SAGA complex), and hda1Dmutants with the WT strain. Except
for gcn5D, none of these mutations significantly affected Pck1p
abundance (Figure 3C). Consistent with this finding, neither
K514R nor K514Q mutations significantly affected Pck1p abun-
dance (Figure 3C). We checked PCK1 mRNA levels in HAT and
HDAC deletion mutants during a diauxic shift, and observed
that PCK1 mRNA increased 8-fold in esa1-531 grown at
nonpermissive temperature, and decreased slightly in sir2D
(Figure 3D). Interestingly, PCK1 mRNA increased 3-fold in
hda1D, and decreased significantly in gcn5D (Figure 3D),Cell 136, 1073–1084, March 20, 2009 ª2009 Elsevier Inc. 1075
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Figure 2. In Vitro and In Vivo Detection of Acetylated K514 of Pck1p
(A and B) Substitution of K514 with arginine (K514R) diminished in vitro acetylation of Pck1p by the NuA4 complex. A conventional HAT activity assay revealed
that Pck1p, but not Pck1p-K514R (both purified from overexpression strains), was acetylated in vitro by the NuA4 complex. The results are presented in a bar
graph with error bars indicating ±1 SEM from three biological replicates. Double asterisk p < 0.01 and triple asterisk p < 0.001 (Student’s t test). (B) Prominent
in vitro acetylation of purified Pck1p purified from the esa1-531mutant grown at nonpermissive temperature, but not Pck1p-K514R, by the NuA4 complex. See
Figure 1B legend for assay protocols.
(C) Overexpressed Pck1p was acetylated at K514 in vivo by the NuA4 complex. See Figure 1C legend for assay protocols.
(D) In vivo acetylation of endogenous Pck1p in WT, esa1-531, pck1-K514R, and sir2D mutants was assessed using the protocols described in Figure 1C.
(E) In vivo acetylation of overexpressed Pck1p in wild-type and pck1-K19R mutant. Acetylation at K19 contributes minimally to the entire acetylation fraction of
Pck1p.
(F) The NuA4 complex efficiently acetylated purified Pck1p overexpressed in pck1-K19R mutant in vitro.suggesting that Hda1p and Gcn5p repress and activate PCK1
transcription via chromatin modification, respectively, on nonfer-
mentable carbon sources (NFCSs). These results confirm
previous functional genomics studies of yeast HDACs, in which
Hda1p deacetylates (and probably suppresses) Hda1-affected
subtelomeric domains in subtelomeric chromatin containing glu-
coneogenic genes (Robyr et al., 2002), and clarify the previously
unexplained finding that yeast SAGA is essential for growth on
ethanol (van Voorst et al., 2006).
In addition, we observed that C-terminally GFP-tagged Pck1p
localized to both nucleus and cytoplasm, independent of
(de)acetylation status (Figure S6). Because Pck1p functions as
a homotetramer in vivo (Ravanal et al., 2003), we also examined
Pck1p oligomerization status by size exclusion chromatography;
its oligomerization was normal in esa1-531 and sir2D (Figure S7).
Acetylation of Pck1p Controls Enzymatic Activity
To determine whether (de)acetylation of Pck1p was physiologi-
cally relevant, we monitored viability of various mutants on
NFCSs. Gluconeogenesis is essential for yeast growth on
NFCSs, such as ethanol and glycerol, allowing replenishment
of sugar phosphate stores important for biomass generation1076 Cell 136, 1073–1084, March 20, 2009 ª2009 Elsevier Inc.(Schuller, 2003). Deletion of PCK1 is lethal when ethanol is the
only available carbon source (Figure 4A). Adding glycerol and
ethanol (GE) bypasses the need of Pck1p in the early stages of
the pathway and rescues pck1D lethality (Figure 4A). Similar
phenotypes were observed for esa1-531 grown at a semipermis-
sive temperature but not at permissive temperature (Figure S8),
and for the pck1-K514R mutant grown on either ethanol or GE,
suggesting acetylation at K514 of Pck1p is crucial for function
(Figure 4A). There was no additive effect on the growth defect
in the esa1-531/pck1-514R double mutant on NFCSs
(Figure S9). Consistent with this result, substitution of K514
with glutamine (K514Q) almost completely rescued the esa1-
531 growth defect on ethanol or GE (Figure 4A). Moreover, dele-
tion of SIR2 did not rescue pck1-K514R growth defects on
ethanol or GE, suggesting that K514 is the only Pck1p lysine
residue targeted by Sir2p (Figure S10). Overexpression of SIR2
by introducing an extra copy of SIR2 on a centromeric plasmid
(2X SIR2 in Figure S11A) does not significantly affect growth
on glucose, ethanol, or GE (Figure S11B). Although both GCN5
and HDA1 regulate PCK1 at the mRNA level, only deletion of
GCN5 showed similar growth defects, consistent with its effect
on Pck1p abundance (Figures 3C, 3E, and 4B). Interestingly,
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Figure 3. Sir2p Deacetylates Pck1p K514
(A and B) Pck1p is deacetylated in vivo and in vitro
by Sir2p. Overexpressed Pck1p was purified from
WT, hda1D, rpd3D, or sir2Dmutants and immuno-
precipitated using anti-pan-acetyl-lysine mono-
clonal antibody as described in Figure 1E. Acety-
lated Pck1p increased significantly in sir2D strain
when compared with WT, hda1D, and rpd3D.
Purified Sir2-TAP, but not Hda1-TAP, efficiently
deacetylated Pck1p in vitro in an NAD+-dependent
manner.
(C) Endogenous protein levels of Pck1p were
detected by immunoblot analysis of the whole-
cell extracts derived from cells expressing
C-terminally Myc-tagged Pck1p.
(D) Levels of PCK1 mRNA were detected by
RT-PCR in WT, esa1-531, sir2D, gcn5D, and
hda1D strains. The results are presented in a bar
graph with error bars indicating ±1 SEM from three
biological replicates. Single and triple asterisks
indicate p < 0.05 and p < 0.001 (Student’s t test),
respectively. Primers used in the RT-PCR reac-
tions are provided in Table S3.both pck1-K514Q and sir2D enhanced growth on high concen-
trations of ethanol (Figure 4C), indicating the contribution of
gluconeogenesis to ethanol tolerance in yeast.
These results prompted us to investigate whether acetylation
directly affects Pck1p enzymatic activity. An enzyme assay
(Figure 4D) was used to assess the ability of Pck1p to convert
PEP and ADP to OAA and ATP, coupled with the conversion of
OAA to malate by malate dehydrogenase; in this standard assay
for Pck1p activity the latter activity is detected spectrophoto-
metrically via NADH consumption (Baly et al., 1985). We
observed that Pck1p purified from esa1-531 was defective in
the reaction under a wide range of ADP concentrations (Figures
4E and 4F). Though pck1-K514R diminished Pck1p enzymatic
activity (Figure 4E; the curves of pck1-K514R and esa1-531 over-
lapped), pck1-K514Q did not cause significant changes in
activity (Figure S12), but partially restored the impaired enzy-
matic activity of Pck1p purified from esa1-531 grown at the
nonpermissive temperature (Figure 4E), indicating that acetyla-
tion at K514 of Pck1p is important in maintaining maximal
activity. Consistent with the insignificant contribution of K19 to
the overall Pck1p acetylation status, pck1-K19R minimally
affected activity (Figure S13). Finally, the Km and Vmax of Pck1p
purified from esa1-531 differ substantially from those from WT
cells (Figure 4F).
Loss of PCK1 Activity Blocks Chronological Life-Span
Extension in Water Starvation
The enzyme-substrate relationship between Sir2p and Pck1p
and Pck1p’s ability to convert ethanol to glucose in postdiauxic
cells suggest a possible connection between gluconeogenesis
and longevity. To test this hypothesis, we investigated whether
Pck1p is involved in CLS extension caused by water starvation.The CLS of various mutants in the BY4742 background was
assessed by holding saturated cultures in SCmedium containing
2% glucose, a standard culture condition to propagate yeast
cells in the laboratory, and in water, a severe form of starvation,
causing entry into a low metabolic state and a dramatic exten-
sion of CLS (Fabrizio et al., 2005; Fabrizio and Longo, 2003). In
agreement with a previous study (Fabrizio et al., 2005), the chro-
nological life span of a sir2D mutant was extended significantly
compared with WT in water but not in SC medium containing
glucose (Figure 5A). By contrast, knockout of PCK1 dramatically
reduced CLS in both water and glucose-containing medium
(Figure 5A). K514 acetylation and hence enzymatic activity of
Pck1p was involved because the pck1-K514R mutation, like
pck1D, shortened CLS both in water and glucose-containing
medium, whereas the pck1-K514Q mutation, just like sir2D,
extends CLS in water (Figure 5A). Moreover, deletion of SIR2
did not alter the life span of pck1D, pck1-K514R, and pck1-
K514Q mutants, indicating PCK1 was epistatic to SIR2 in this
pathway and implicating it as the key Sir2p substrate controlling
this form of longevity (Figure 5B). The esa1-531 mutant has an
even shorter CLS than pck1D in both 2% glucose and water at
30C, a semipermissive temperature; at the permissive temper-
ature there is little difference (25C; Figure S14). This finding
suggests that additional NuA4 substrates besides Pck1p control
yeast CLS. In contrast, Pck1p acetylation status had minimal
effect on replicative life span of yeast cells grown in YPD
(Figure S15), thus Pck1p is not involved in the replicative
pathway.
On the basis of previous findings that uptake of extracellular
ethanol mediates extension of CLS, and that extracellular
ethanol is depleted faster in long-lived mutants such as sir2D
(Fabrizio et al., 2005), we measured the ethanol concentrationCell 136, 1073–1084, March 20, 2009 ª2009 Elsevier Inc. 1077
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Figure 4. Pck1p Acetylation Controls Activity
(A) Growth of WT, pck1D, esa1-531, pck1-K514R (K514R), pck1-K514Q (K514Q), and esa1-531 pck1-K514Q (esa1-531 K514Q) double-mutant strains was
examined on SC medium plates containing 2% glucose, 3% ethanol, or 2% glycerol + 2% ethanol (GE).
(B) Growth of WT, esa1-531, gcn5D, sir2D, hda1D, and pck1D strains was monitored in the same conditions as described above.
(C) Growth of WT, pck1D, pck1-K514Q (K514Q), and sir2D was compared on SC plates containing 2% glucose, 6% ethanol, or 15% ethanol.
(D) Pck1p activity was assayed in a coupled reaction, in which oxaloacetate (OAA) formed from phosphoenol pyruvate (PEP) was reduced to malate by NADH in
the presence of malate dehydrogenase (MDH). Rate of NADH oxidation was measured at 340 nm.
(E) Enzymatic activity of Pck1p purified fromWT, esa1-531, pck1-K514R, and esa1-531 pck1-K514Qmutants wasmeasured by consumption of NADH as a func-
tion of time. The curves of esa1-531 and pck1-K514R overlapped with each other.
(F) Km and Vmax values of Pck1p purified from WT and esa1-531 were determined based on Michaelis-Menten kinetics.in the CLS-conditioned medium. Interestingly, extracellular
ethanol concentration was inversely proportional to CLS.
Ethanol concentration remained high until day 7 in short-lived
mutants, including esa1-531 at semipermissive temperature
(30C), pck1D, and pck1-K514R; in long-lived mutants, including
sir2D and pck1-K514Q, extracellular ethanol was depleted as
early as day 3 (Figure 5C). Similar to the effect on CLS, PCK1
was epistatic to SIR2 in the mechanism controlling consumption
of extracellular ethanol, as deletion of SIR2 resulted in only1078 Cell 136, 1073–1084, March 20, 2009 ª2009 Elsevier Inc.minimal changes of ethanol concentration in pck1D, pck1-
K514R, and pck1-K514Q mutants (Figure 5C).
We further examined the resistance of thesemutants to oxida-
tive stress resulting from exposure to high levels of H2O2, gener-
ating reactive oxygen species (Lin et al., 2002; Scherz-Shouval
and Elazar, 2007). Consistent with a previous study (Fabrizio
et al., 2005), a sir2Dmutant in stationary phase (day 3 cells) rela-
tive to the exponential growth phase (day 1 cells) wasmore resis-
tant to H2O2 stress (Figure S16). Although pck1D was less
resistant overall, the sensitivity of pck1-K514R and pck1-K514Q
to oxidative stress was similar to the WT (Figure S16) regardless
of the growth phase, suggesting that (de)acetylation status and
enzymatic activity of Pck1p play a minimal role in this function.
Acetylation of Human Pck1 and Glucose Secretion
Depends on TIP60 Activity
Two isozymes of PEPCK exist in mammalian cells: cytosolic
(PCK1) and mitochondrial (PCK2) (Hanson and Reshef, 1997).
The mammalian Pck1 (PEPCK-C) catalyzes the first committed
step of gluconeogenesis in liver and kidney (Rognstad, 1979)
and induces glyceroneogenesis in liver and adipose tissue
(Reshef et al., 2003); the physiologic role of Pck2 (PEPCK-M)
has not been well established (Hanson and Reshef, 1997).
Both mammalian isozymes show low sequence identity with
A
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Figure 5. PCK1Activity Extends Chronolog-
ical Life Span under Water Starvation
(A and B) Chronological survival of wild-type (WT;
BY4742), esa1-531, pck1D, sir2D, pck1-K514R,
pck1-K514Q, sir2D pck1D, sir2D pck1-K514R,
and sir2D pck1-K514Q in liquid synthetic complete
medium containing either 2% glucose or water at
30C was assessed. Error bars indicate ±1 SEM
from three biological replicates.
(C) Ethanol concentration in cell-free media from
day 1, 3, 5, and 7 cultures of wild-type (WT;
BY4742), esa1-531, pck1D, sir2D, pck1-K514R,
pck1-K514Q, sir2D pck1D, sir2D pck1-K514R,
and sir2D pck1-K514Q at 30C was measured.
Error bars indicate ±1 SEM from three biological
replicates.
yeast Pck1p (Figure S17) and utilize GTP
instead of ATP (Utter and Kolenbrander,
1972). However, both ATP- and GTP-
dependent enzymes share similar active
site sequence consensus motifs, sug-
gesting conserved catalytic mechanism
(Matte et al., 1997).
To examine this hypothesis, plasmid-
borne full-length coding regions of both
human PEPCK genes were introduced
into the yeast pck1D mutant, and growth
of transformants on NFCSs was exam-
ined. As illustrated in Figure 6A, only
human PCK1 but not PCK2 could partially
complement the function of yeast PCK1,
suggesting that human Pck1 shares glu-
coneogenic mechanism with yeast
Pck1p. To further investigate the role of
acetylation in controlling human Pck1
enzymatic activity, we used short hairpin
RNAs (shRNAs) to efficiently knockdown
TIP60 and SIRT1, the human homologs
of yeast ESA1 and SIR2, respectively, in
human hepatocellular carcinoma
(HepG2) cells (Figures S18A and S18B).
Transcription of human PCK1 depends on SIRT1 in primary
hepatocytes (Rodgers et al., 2005). Consistent with this, knock-
down of SIRT1 reduced the endogenous human Pck1 level
(50%) in HepG2 cells (Figure 6B). By IP, we found that human
Pck1was acetylated in HepG2 cells (Figure 6C), but not in human
embryonic kidney 293T cells (data not shown). Whereas knock-
down of TIP60 did not affect the endogenous human Pck1 level
(Figure 6B), it dramatically diminished the acetylation fraction of
human Pck1 compared with GFP knockdown control
(Figure 6C). However, knockdown of SIRT1 showed no detect-
able effect on human Pck1 acetylation (Figure 6C), suggesting
a distinct deacetylation mechanism in mammalian cells. Treat-
ment with HDAC inhibitors such as trichostatin A (TSA, a class
I/II HDAC inhibitor) or nicotinamide (NAM, a class III HDAC inhib-
itor) (Neugebauer et al., 2008) increased the acetylation fractionCell 136, 1073–1084, March 20, 2009 ª2009 Elsevier Inc. 1079
A B
E
C D
Figure 6. TIP60-Dependent Acetylation of Human Pck1 and Glucose Production
(A) Human PCK1 (hPCK1) but not PCK2 (hPCK2) rescued the growth defect of yeast pck1D mutant on ethanol and GE. Growth was monitored as described in
Figure 4A.
(B) Endogenous human Pck1 level decreased in HepG2 cells when SIRT1 was silenced.
(C) Knockdown of TIP60 diminished the in vivo acetylation of human Pck1 in HepG2 cells.
(D) Treatment of histone deacetylase inhibitors (HDACi) such as trichostatin A (TSA) or nicotinamide (NAM) increased the in vivo acetylation of human Pck1 in
HepG2 cells.
(E) Glucose output of HepG2 cells was dependent on TIP60. The results are presented in a bar graph with error bars indicating ±1 SEM from three biological
replicates. Double asterisk indicates p < 0.01 (Student’s t test).of human Pck1 in HepG2 cells (Figure 6D). Consistent with the
hypothesis that acetylation controls enzymatic activity of human
Pck1 in vivo, the amount of glucose secreted into glucose-free
medium significantly declined (40%) in TIP60 knockdown
HepG2 cells, but knockdown of SIRT1 had no significant effect
(Figure 6E).
DISCUSSION
We report a proteome-wide search for nonhistone substrates of
the essential yeast NuA4 complex. We have validated 13 in vivo
substrates among 20 candidates, 7 of which are cytoplasmic
proteins involved in metabolic pathways responding to extracel-
lular nutrient sources and intracellular energy status. It is note-
worthy that several functions (e.g., gluconeogenesis and
autophagy) of NuA4 metabolic protein substrates are induced
by limiting extracellular nutrient sources (Schuller, 2003; Take-
shige et al., 1992; Zaman et al., 2008). Considering that acetyla-
tion of Pck1p by NuA4 is important for its gluconeogenic activity,
it is reasonable to speculate that NuA4might act as a central hub
to help yeast cells meet the challenge of nutrient deprivation by
acetylating these nonhistone substrates, and activating a meta-
bolic network.
Several functions are important in the extension of yeast life
span under calorie restriction or starvation, including stress1080 Cell 136, 1073–1084, March 20, 2009 ª2009 Elsevier Inc.response (Fabrizio et al., 2005), autophagy (Powers et al.,
2006), decreased ribosome biogenesis and protein translation
(Kaeberlein et al., 2005), respiration (Lin et al., 2002), and
changes in carbon metabolism (Ashrafi et al., 2000). The target
of rapamycin (TOR) signaling pathway is regarded as a central
negative regulator of these functions (Kaeberlein et al., 2005;
Powers et al., 2006) to block extension of life span. Other genes,
such as SIR2, might also be important because of additive
effects on life-span extension when both the TOR pathway and
SIR2 function are disrupted compared with either single muta-
tion (Fabrizio et al., 2005). Our finding that acetylation control
of Pck1p gluconeogenic activity to convert ethanol to glucose
is crucial for longevity extension provides evidence that NuA4
might be a central positive regulator that opposes TOR in CLS
extension under water starvation. NuA4 might further modulate
TOR function by acetylating Tap42p, a downstream effector in
TOR pathway (Duvel et al., 2003) uncovered as a substrate in
this study. It also provides another insight into how SIR2 plays
an antagonistic role in extending CLS. Considering that tran-
scription of PCK1 is repressed by even trace amounts of glucose
(as low as 0.001% in the medium; Yin et al., 2000), the lack of
effect on RLS by deleting PCK1 or altering the acetylation status
of its encoding protein is unsurprising (Figure S15). However,
NuA4 might regulate RLS through acetylating Nnt1p, the yeast
putative nicotinamide N-methyltransferase with a role in rDNA
A B
Figure 7. Schematic Model for Regulation of Pck1p Activity in Yeast and Humans
A ‘‘triple switch’’ (transcription of PCK1, acetylation of Pck1p, and allosteric modification of PC) in the gluconeogenesis pathway controls prompt adaptation of
a metabolic flux to energy status in yeast (A) and humans (B). The change of metabolic flux also mediates extension of chronological longevity under water star-
vation in yeast cells. ACS, acetyl-coenzyme A synthetase; AceCS1, acetyl-coenzymeA synthetase 1; PC, pyruvate carboxylase. Solid lines indicate the paths that
have been proved by previous and the present study; dashed lines indicate those paths that were hypothesized as part of the present study.silencing and life-span determination (Anderson et al., 2003).
Interestingly, mice that overexpress PCK1 in skeletal muscle
live longer and are more energetic at an older age (Hakimi
et al., 2007), suggesting a potential role of PCK1 in regulating
longevity in mammals.
Gluconeogenesis is extensively and elaborately regulated to
maintain blood glucose level within a narrow range during fasting
to ensure a steady and continuous glucose supply in mammals
(Burgess et al., 2007). As a crucial enzyme in gluconeogenesis,
mammalian PCK1 transcription is tightly controlled by various
transcription factors in response to varied physiological stimuli,
including dietary carbohydrate content, nutritional status, and
various hormones (Beale et al., 2004; Hanson and Reshef,
1997). Fasting also induces PCK1 expression in liver and
adipose tissue (Hagopian et al., 2003, 2008; Raab et al., 2005).
Failure of this exquisite transcriptional control mechanism
causes dysregulated overexpression of PCK1 in liver and inap-
propriately high levels of hepatic gluconeogenesis in all forms
of diabetes (Burgess et al., 2007; Permutt and Hattersley,
2000). Previous studies have focused mainly on transcriptional
regulation of PCK1. However, our findings suggest that HATs
and HDACs not only regulate PCK1 transcription (by Gcn5p
and Hda1p) in yeast but also regulate Pck1p activity posttransla-
tionally both in yeast and humans (Figure 7). Whereas acetyl-
CoA synthetase activates acetate produced by nonfermentable
sugar metabolism to acetyl-CoA during diauxic shift in yeast(Haurie et al., 2001; van den Berg et al., 1996), fasting activates
expression of SIRT1 in mammals, which in turn promotes the
production of acetyl-CoA by deacetylating and activating
AceCS1 (Schwer and Verdin, 2008). The elevated intracellular
acetyl-CoA concentration favors the transcription of PCK1 and
the stimulatory acetylation of Pck1p. Our results suggest that
acetylation of Pck1p increases its enzymatic activity through
mechanisms other than regulating macromolecular abundance,
subcellular localization, or quaternary structure of the protein.
Based on the crystal structure of the Escherichia coli ortholog
(Delbaere et al., 2004), which shares a high level of amino acid
sequence homology with yeast Pck1p (Figure S19), acetylation
at K514 might cause a conformational change of the C-terminal
mononucleotide-binding domain in favor of substrate binding or
catalysis of the phosphoryl-transfer reaction. Despite sharing
minimal primary structural identity with yeast Pck1p (Ravanal
et al., 2003; Figure S17), we found that human Pck1 is also acti-
vated by TIP60-dependent acetylation. Unlike yeast Pck1p,
which is deacetylated exclusively by Sir2p, human Pck1p might
be deacetylated by multiple deacetylases. Upregulation of
Pck1p transcription and activity, and allosteric modulation of
the activity of pyruvate carboxylase (another key enzyme of the
gluconeogenesis pathway) by acetyl-CoA (Pronk et al., 1996),
might together provide a ‘‘triple switch’’ to ensure a prompt
adaptation of the gluconeogenic flux to energy status in yeast
and possibly human cells (Figure 7).Cell 136, 1073–1084, March 20, 2009 ª2009 Elsevier Inc. 1081
In summary, we have found extracellular functions of yeast
NuA4 complex in regulating gluconeogenesis and chronolog-
ical life span. PEPCK gluconeogenic activity, etiologically
important in human diabetes, is acetylated in both yeast and
humans. Characterization of the structural basis of this acetyla-
tion control mechanism, as well as identification of the HDACs
responsible for reversing the acetylation of human Pck1 in
human liver, will be crucial for further clarifying how blood
glucose level is maintained within a remarkably narrow range.
Besides Pck1p, understanding how other metabolic protein
substrates are regulated by NuA4 in response to starvation
and their possible roles in extension of chronological life span
will also be an important next step. Lastly, a similar approach
using a human proteome microarray will help identify the
HATs/HDACs responsible for the increasing number of acety-
lated human proteins.
EXPERIMENTAL PROCEDURES
Yeast Strains and Constructs
Yeast strains used in this study are listed in Table S2 and oligonucleotides are
listed in Table S3. Detailed information is provided in Supplemental Data.
Acetylation Reactions on Yeast Proteome Microarrays
A 200 ml reaction mixture containing 50 mM sodium butyrate, 5 mM DTT and
5 mM PMSF, 0.025 mCi [14C]-Acetyl-CoA (GE Healthcare, Piscataway, NJ;
0.05 mCi/mL, 8 mCi/mmol), with or without 4 mg of NuA4, was prepared in
reaction buffer (250 mM Tris-HCl [pH 7.5], 25% glycerol, 0.5 mM EDTA,
and 250 mM KCl). A yeast proteome microarray (Zhu et al., 2001) was incu-
bated with the reaction mixture at 30C for 1 hr, and then subjected to three
15 min washes with 50 mM NaHCO3-Na2CO3 (3:1) (pH 9.3). The acetylation
signals were then visualized by autoradiography after exposure to X-ray film
for 20 days, scanned, and saved as TIFF files. The TIFF images were pro-
cessed by assigning an artificial green color to each brightened spot and
analyzed using GenePix software to determine relative acetylation levels.
After subtraction of backgrounds, protein spots with median signal intensity
greater than an arbitrary cutoff value of 3000 (determined based on visual
inspection) were chosen as candidate substrates of NuA4 for further valida-
tion studies.
In Vivo Acetylation
GST-tagged Pck1p driven by the GAL1 promoter was purified fromWT, esa1-
531, pck1-K514R, and the esa1-531pck1-K514R double mutant after protein
induction at 37C (nonpermissive temperature) for 2 hr, or from WT, hda1D,
rpd3D, and sir2D strains after protein induction at 30C for 4 hr, immunopre-
cipitated by incubating with 30 ml protein A-sepharose beads (GE Healthcare)
conjugated with 6 ml of mouse monoclonal anti-acetylated-lysine (9681S; Cell
Signaling, Danvers, MA) in the presence of a cocktail of HDAC inhibitors
(100 mM Trichostatin A, 50 mM nicotinamide, and 50 mM sodium butyrate)
at 4C for 3 hr. To detect acetylation of endogenous C-terminally Myc-tagged
Pck1p from WT, esa1-531, pck1-K514R, and sir2D mutants, whole-cell
extracts were precleared by incubating with 30 ml protein A-sepharose beads
at 4C for 90 min, followed by IP as described previously. After extensive
washes with 500 ml of washing buffer (50 mM HEPES [pH 7.0] and 100 mM
NaCl) at 4C four times (10 min each time), the immunoprecipitate was dena-
tured in 20 ml of 23 SDS sample buffer, resolved by SDS-PAGE, transferred to
nitrocellulose membranes and probed with rabbit polyclonal anti-GST anti-
body (AB3282; Millipore, Billerica, MA) or mouse monoclonal anti-Myc anti-
body (SC-40; Santa Cruz, Santa Cruz, CA) for purified or endogenous
Pck1p, respectively. For competition binding, 150 mg of acetylated BSA
(AM26141; Ambion, Austin, TX) was used, and an equal amount of unacety-
lated BSA (B9001S; New England BioLabs, Ipswich, MA) was used in parallel
samples as control.1082 Cell 136, 1073–1084, March 20, 2009 ª2009 Elsevier Inc.Pck1p Enzymatic Activity Assay
The activity of purified Pck1p was assayed as described previously (Baly et al.,
1985). In brief, enzymatic activity of Pck1p was assayed using a coupled
system in which the oxaloacetate produced in the reaction was reduced to
malate by NADH in the presence of malate dehydrogenase. The NADH
consumption rate was measured spectrophotometrically at 340 nm. Equal
amount (50 mg) of purified GST-tagged enzyme was added to a 1 ml reaction
mixture (10 mM potassium phosphoenolpyruvate, 10 mM NaHCO3, 2 mM of
MnCl2, 1mMADP, 12mM sodium aspartate, 80mM Tris-HCl (pH 8.8), 14 units
malate dehydrogenase, and 0.15 mM NADH) for each reaction. Samples
without NADH served as a blank control, and samples without Pck1p as
a negative control.
Chronological Life Span and Ethanol Measurement
Chronological life span of yeast cells grown in either synthetic complete
medium (with a 4-fold excess of the supplements histidine, leucine, trypto-
phan, and uracil) containing 2% glucose, 2% glycerol and ethanol, or water
was measured as described (Fabrizio and Longo, 2007). In either culture
condition, colony-forming units (CFUs) were measured every 48 hr. The
number of CFUs on day 3 was considered the initial survival (100%). The
ethanol concentration in medium collected from day 1, 3, 5, and 7 yeast
cultures was analyzed with a colorimetric ethanol assay kit (DIET-500;
BioAssay Systems, Hayward, CA).
Mammalian Cell Culture and Treatment
HepG2 cells were cultured in minimal essential medium (MEM; Invitrogen,
Carlsbad, CA) containing 10% fetal bovine serum (Invitrogen), 100 units/ml
penicillin and 100 mg/ml streptomycin at 37C in a humidified atmosphere con-
taining 5% CO2. The shRNA (obtained from the RNAi Consortium human
lentiviral shRNA library) targeting GFP, TIP60 (TRCN0000020314,
TRCN0000020315, and TRCN0000020316), or SIRT1 (TRCN0000018979,
TRCN0000018980, and TRCN0000018981) were used for transfection of the
packaging HEK293T cells with helper vectors using LipofectamineTM 2000
transfection reagent (Invitrogen) according to the manufacturer’s instructions.
Medium containing lentiviral particles and 8 mg/ml polybrene (Sigma-Aldrich,
St. Louis) was used to infect HepG2 cells. Infected HepG2 cells were then
selected in MEM in the presence of 1.25 mg/ml puromycin (Sigma-Aldrich).
Knockdown efficiency of TIP60 and SIRT1 was assayed by immunoblotting
and RT-PCR. When treated with histone deacetylase inhibitors (HDACi), TSA
(100 mM; Sigma-Aldrich) or NAM (5 mM; Sigma-Aldrich) was added in the
culturemedium 6 hr prior to harvest cells for preparation of whole-cell extracts.
Glucose Production
The amount of glucose secreted by HepG2 cells in media was assayed as
described previously (Yoon et al., 2001). HepG2 cells expressing shRNAs of
GFP control, TIP60, or SIRT1 were cultured in six-well plates (1.4 3 106 cells
per well) in MEM with 10% FBS. The medium was replaced with 2 ml of
glucose production buffer consisting of glucose-free MEM (pH 7.4), without
phenol red, supplemented with 2 mM sodium pyruvate and 20 mM sodium
lactate. After a 3 hr incubation, half of the glucose production buffer was
collected and the glucose concentration was measured with a colorimetric
glucose assay kit (GAGO20; Sigma-Aldrich). The readings were normalized
to the total protein content determined from the whole-cell extracts.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, nineteen
figures, and three tables and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(09)00264-5.
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